Combining the strength of genomics, nanoparticle technology, and direct intraductal delivery for breast cancer treatment

10.1186/bcr3656

Saved in:
Bibliographic Details
Main Authors: Teo, W.W, Sukumar, S
Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
Format: Article
Published: 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/181501
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-181501
record_format dspace
spelling sg-nus-scholar.10635-1815012020-10-27T14:27:56Z Combining the strength of genomics, nanoparticle technology, and direct intraductal delivery for breast cancer treatment Teo, W.W Sukumar, S CANCER SCIENCE INSTITUTE OF SINGAPORE doxorubicin nanoparticle small interfering RNA homeodomain protein nanoparticle small interfering RNA transcription factor article atypical ductal hyperplasia breast cancer cancer model carcinogenesis gene silencing gene targeting genomics human immune response immunity intraductal drug administration microarray analysis nonhuman transgenic mouse animal experimental mammary neoplasm gene silencing genetics pathology Animals Gene Silencing Homeodomain Proteins Mammary Neoplasms, Experimental Nanoparticles RNA, Small Interfering Transcription Factors 10.1186/bcr3656 Breast Cancer Research 16 2 306 2020-10-27T11:07:37Z 2020-10-27T11:07:37Z 2014 Article Teo, W.W, Sukumar, S (2014). Combining the strength of genomics, nanoparticle technology, and direct intraductal delivery for breast cancer treatment. Breast Cancer Research 16 (2) : 306. ScholarBank@NUS Repository. https://doi.org/10.1186/bcr3656 14655411 https://scholarbank.nus.edu.sg/handle/10635/181501 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic doxorubicin
nanoparticle
small interfering RNA
homeodomain protein
nanoparticle
small interfering RNA
transcription factor
article
atypical ductal hyperplasia
breast cancer
cancer model
carcinogenesis
gene silencing
gene targeting
genomics
human
immune response
immunity
intraductal drug administration
microarray analysis
nonhuman
transgenic mouse
animal
experimental mammary neoplasm
gene silencing
genetics
pathology
Animals
Gene Silencing
Homeodomain Proteins
Mammary Neoplasms, Experimental
Nanoparticles
RNA, Small Interfering
Transcription Factors
spellingShingle doxorubicin
nanoparticle
small interfering RNA
homeodomain protein
nanoparticle
small interfering RNA
transcription factor
article
atypical ductal hyperplasia
breast cancer
cancer model
carcinogenesis
gene silencing
gene targeting
genomics
human
immune response
immunity
intraductal drug administration
microarray analysis
nonhuman
transgenic mouse
animal
experimental mammary neoplasm
gene silencing
genetics
pathology
Animals
Gene Silencing
Homeodomain Proteins
Mammary Neoplasms, Experimental
Nanoparticles
RNA, Small Interfering
Transcription Factors
Teo, W.W
Sukumar, S
Combining the strength of genomics, nanoparticle technology, and direct intraductal delivery for breast cancer treatment
description 10.1186/bcr3656
author2 CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet CANCER SCIENCE INSTITUTE OF SINGAPORE
Teo, W.W
Sukumar, S
format Article
author Teo, W.W
Sukumar, S
author_sort Teo, W.W
title Combining the strength of genomics, nanoparticle technology, and direct intraductal delivery for breast cancer treatment
title_short Combining the strength of genomics, nanoparticle technology, and direct intraductal delivery for breast cancer treatment
title_full Combining the strength of genomics, nanoparticle technology, and direct intraductal delivery for breast cancer treatment
title_fullStr Combining the strength of genomics, nanoparticle technology, and direct intraductal delivery for breast cancer treatment
title_full_unstemmed Combining the strength of genomics, nanoparticle technology, and direct intraductal delivery for breast cancer treatment
title_sort combining the strength of genomics, nanoparticle technology, and direct intraductal delivery for breast cancer treatment
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/181501
_version_ 1683425045396848640